Attending BioEurope again!

e-Projection will back in Europe for the exciting BioEurope conference again! This time we will be in the beautiful city of Copenhagen from November 5-7. We will be meeting with brand new faces as well as catching up with others we have worked in the past. If you are going to be in the city […]


Effects of Quitting Alcohol: Personal Experience

Fifteen years ago, I decided to quit one habit which I have kept for more than a decade, smoking. I do not remember if there were any immediate health effects felt from doing so, but perhaps at least the good thing was that I have not experienced any negative effects from smoking tobacco. My father […]


Attractive Opportunities in Japanese Pharmaceuticals: A Closer Look

At a certain point in its corporate life cycle, biotech companies start to consider local deals; that is, licensing their product’s rights in certain geographies to local pharmaceutical companies. The primary reason of doing so is cash. Biotechs are always running lean, and it is almost intentionally kept that way. But time to time, it […]


Attending BioPharm America and NLS Days this year again

This September, e-Projection will be planning for another world tour for two consecutive years. BioPharm America: September 5–6, 2018, Hynes Convention Center, Boston, MA Nordic Life Science Days: September  10-12, 2018, September, Stockholm Waterfront Congress Center, Nils Ericsons Plan 4, Stockholm It will be an exiting two weeks both in the US and in Europe. Come join […]


Presentation at the Japan Pharma & Governance Tour at UBS Securities

I was asked to join and present at a panel discussion organised by UBS Securities with the fund managers, to talk about the Japanese pharma market in general and also about the recent Takeda/Shire deal. I am sharing the slides that I used there, where I am discussing about the facts and implications of the […]


Pricing rules in Japan; an awkward development

June 8, 2018 Tosh Nagate, CEO at e-Projection K.K. To make assumptions of the price of any product, from chocolate bars to computers, is one of the most daunting tasks for a product manager, but if it comes to drug pricing, the challenge is staggering. In many of the advanced economies, unlike any other product, […]


Conference Report

14th Annual Meeting of the Japanese Society of Medical Oncology July 28, 2016 Crizotinib vs Alectinib Miyako Satouchi Department of Thoracic oncology, Hyogo Cancer Center Program Came back to JSMO, this time in Kobe! Although most of the discussion is stemming from those fancy-looking immune checkpoint inhibitors, data from the so-called 2nd gen ALK inhibitors […]


e-Projection to be attending the BioJapan 2016 conference

e-Projection will be attending the BioJapan 2016 conference on Oct. 12~14 at Yokohama, Japan. We are accessible through the Partnering System, feel free to contact us if you are interested in any of our services through the System.


e-Projection to be attending the Bio Europe 2016 conference

e-Projection will be attending the Bio Europe 2016 conference on Nov. 7~9 at Cologne, Germany. We are accessible through the PartneringOne System, feel free to contact us if you are interested in any of our services through the System, or just drop us a message from the Contact us page.


The Constitution as a Commitment Device and its Limits

Although I studied law when I was in undergrad, I should not say that I am an expert on it. Japanese collage education only by itself is mostly not enough to rear a cutting edge expert. In the sector of social science, especially the faculty of law is usually positioned as a place which graduates […]